Glenmark Pharmaceuticals today reported 252% surge in consolidated net profit for the fourth quarter ended March 31, 2008, at Rs 218.96 crore as against Rs 62.20 crore in the corresponding quarter a year ago.


</p><tr><td><p class='TableClas'></p><P class='TableClas'><DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>According to a release issued by Glenmark to the BSE today, the group's Q4FY08 total income grew 70.5% to Rs 606.80 crore from Rs 355.93 crore in Q4FY07.</P>
</p><p class='TableClas'>The group has posted 103.6% rise in FY08 consolidated net at Rs 631.26 crore when compared with Rs 310.06 crore reported in FY07. Total income has increased 64.2% to Rs 2,022.90 crore from Rs 1,232.22 crore.<BR></P>
</p><p class='TableClas'></p></table>


Glenmark Pharma Q4 net soars 252%

More From This Section

Posco land acquisition resumes amid protests

Diageo to buy half of Mallya's South Africa beer biz

Average money spent for new players dips

'IndiGo did not comply with AAC guidelines'

Explore News